Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 466

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 466
---
. This allocation is consistent with the guidance of IFRS3, Business Combinations, which requires that identifiable intangible assets and goodwill be recognized at their respective fair values as of the acquisition date. The allocation is subject to change upon completion of the Merger and finalization of the purchase price allocation analysis to be conducted upon Closing of the Merger. 270

|                                             |     | Amount |            |
|:--------------------------------------------|:----|:-------|-----------:|
| Purchase price consideration(1)             |     | $      | 19,450,683 |
| Total consideration                         |     | $      | 19,450,683 |
| Assets acquired:                            |     |        |            |
| Cash                                        |     | $      |  4,219,094 |
| Prepayments and other current assets        |     |        |    560,157 |
| Property and equipment                      |     |        |      7,290 |
| Intangible assets-IPR&D & Goodwill(2)       |     |        | 15,490,906 |
| Total assets acquired                       |     |        | 20,277,447 |
| Liabilities assumed:                        |     |        |            |
|                                             |     | $      |    826,764 |
| Total liabilities assumed                   |     |        |    826,764 |
| Estimated fair value of net assets acquired |     | $      | 19,450,683 |

____________ (1) See Note 5 below. (2) The preliminary purchase price of approximately $19.5 million has been allocated primarily to intangible assets — primarily intangibles assets in -process research and development (IPR&D) and goodwill. This estimate is based on management’s assessment of the currently available information, as a formal third -party valuation has not yet been completed. These indefinite -lived intangible assets will not be amortized but will be tested for impairment at least annually, or more frequently if indicators of impairment arise. (3) These intangible assets are not expected to be deductible for tax purposes. Given the preliminary nature of the purchase price allocation, the final allocation at closing may be adjusted. Any remaining consideration not assigned to identifiable net assets — including IPR&D — will be recognized as goodwill in accordance with IFRS 3, Business Combinations (paragraphs 32 – 34). For purposes of this pro forma presentation, NLS has aggregated indefinite -lived int